US Edition
News from pharmatimes.com
Top pharmatimes.com News
Medical · United StatesThe U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents.See the Story
Fda Approves Ajovy for Migraine Prevention in Children and Teens
75% Center coverage: 4 sources
European UnionSTAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase inhibitor, as monotherapy for…See the Story
European Commission Grants Approval of OGSIVEO® (Nirogacestat) for the Treatment of Adults with ...
100% Center coverage: 1 sources
Eli Lilly · United KingdomA new program to improve access to weight management services across the U.K. National Health Service (NHS) could benefit several obese patients. The initiative, announced Tuesday, combines government and private sector funding to expand holistic care through community, pharmacy, and digital channels. The program is backed by up to $114.61 million (85 million sterling pounds), with the U.K. government contributing as much as 50 million pounds an…See the Story
UK Government, Eli Lilly Partner To Target Obesity Health Gaps - Eli Lilly (NYSE:LLY)
100% Center coverage: 1 sources
